SXTP

0.7263

9.21% -0.0737

Dopo l'orario di chiusura: .71 -0.0163 -2.24%

60 Degrees Pharmaceuticals Inc (SXTP)

Panoramica Notizia Cronologia dei prezzi Perché SXTP Giù? Forum Previsione

Precedente Chiudi:

$0.80

Aprire:

$0.7801

Volume 24 ore:

1.33M

Relative Volume:

0.89

Capitalizzazione di mercato:

$1.67M

Reddito:

$502.40K

Utile/perdita netta:

$-7.91M

Rapporto P/E:

-0.0728

EPS:

-9.972

Flusso di cassa netto:

$-4.32M

1 W Prestazione:

-18.78%

1M Prestazione:

-43.70%

6M Prestazione:

-58.97%

1 anno Prestazione:

-78.41%

Intervallo 1D:

$0.70

$0.80

Intervallo di 1 settimana:

$0.70

$1.20

Portata 52W:

$0.70

$7.1988

60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile

Nome

60 Degrees Pharmaceuticals Inc

Settore

Healthcare (1173)

Industria

Biotechnology (678)

Telefono

202-327-5422

Indirizzo

1025 CONNECTICUT AVENUE NW, WASHINGTON

Dipendente

Cinguettio

Prossima data di guadagno

Ultimi documenti SEC

SXTP's Discussions on Twitter

Confronta SXTP con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
SXTP 60 Degrees Pharmaceuticals Inc	0.7263	1.67M	502.40K	-7.91M	-4.32M	-9.972
VRTX Vertex Pharmaceuticals Inc	461.68	118.90B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	672.98	73.95B	13.85B	4.65B	3.32B	40.41
ARGX Argen X Se Adr	655.13	39.81B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	271.31	34.99B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	123.77	29.67B	3.30B	-501.07M	1.03B	-2.1146

60 Degrees Pharmaceuticals Inc Borsa (SXTP) Ultime notizie

Jan 31, 2025

SXTP stock touches 52-week low at $0.7 amid market challenges - MSN

Jan 31, 2025

Jan 30, 2025

60 Degrees Pharma Announces Closing of $1.043 Million - GlobeNewswire

Jan 30, 2025

60 Degrees Pharma Secures Fresh Capital: Inside the $1M Financing Deal That's Turning Heads - StockTitan

Jan 30, 2025

60 Degrees Pharma Announces $1.043 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - The Manila Times

Jan 29, 2025

Pharma Company's $1M Cash Injection Comes with Hidden UpsideComplete Analysis - StockTitan

Jan 29, 2025

US Futures Point To Cautious Start As Investors Await Fed's Rate Decision: Tesla, Microsoft, Meta Among Stocks In Focus Ahead Of Earnings - Benzinga

Jan 29, 2025

60 Degrees Pharmaceuticals obtains IRB approval for chronic babesiosis therapy trial - Yahoo! Voices

Jan 29, 2025

Why F5 Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket - Benzinga

Jan 29, 2025

Jan 28, 2025

60 Degrees Pharmaceuticals Gets Investigational Review Board Approval for Babesiosis Phase 2 Study - Marketscreener.com

Jan 28, 2025

60 Degrees Pharmaceuticals, Inc. Announces the Approval of an Investigational Review Board Commissioned Phase II Clinical Study - Marketscreener.com

Jan 28, 2025

60 Degrees Pharma Announces IRB Approval of Phase II Study to Evaluate Tafenoquine for Chronic Babesiosis - GlobeNewswire

Jan 28, 2025

Revolutionary Tick-Borne Disease Treatment Gets Green Light: 400,000 Patients Await New Hope - StockTitan

Jan 28, 2025

Jan 21, 2025

Titan Pharma (NASDAQ:TTNP) Stock Quotes, Forecast and News Summary - Benzinga

Jan 21, 2025

Jan 20, 2025

Palatin Technologies Inc (AMEX: PTN) Analysts Expect It Could Climb 93.76% From Current Levels. - Stocks Register

Jan 20, 2025

60 Degrees Pharmaceuticals Inc (NASDAQ: SXTP) Jumps 0.32 Percent In Recent Trading, What Questions Do You Have? – Stocks Register - Stocks Register

Jan 20, 2025

Weiss Ratings Reiterates Sell (E+) Rating for 60 Degrees Pharmaceuticals (NASDAQ:SXTP) - Defense World

Jan 20, 2025

Jan 18, 2025

Corn and Brent Crude calendar spread - The Globe and Mail

Jan 18, 2025

Jan 15, 2025